Table 1.
Cutaneous leishmaniasis (n = 20) | Mucosal leishmaniasis (n = 20) | |
---|---|---|
Age |
23 (13–48) |
37 (12–58) |
Gender (male) |
13 (65%) |
15 (75%) |
Skin test area (mm
2
) |
187 (80–625) |
300 (56–1722) |
Series of pentavalent antimony |
|
|
1 |
17 (85%) |
10 (50%) |
2 |
3 (15%) |
9 (45%) |
3 |
- |
1 (5%) |
Stage of mucosal disease |
|
|
II |
- |
8 (40%) |
III |
- |
8 (40%) |
≥ IV |
- |
4 (20%) |
Months between evaluations | 94 (38–161) | 106 (28–184) |